Interventional CT: 30 years' experience.
CT-guided procedures remain an important tool for diagnosis and tissue acquisition for primary diagnosis and molecular/tissue correlation. New imaging devices such as MDCT and PET/CT will improve diagnosis but percutaneous procedures will be needed to confirm and support new molecular and DNA treatments. Coagulopathic patients can be treated with LIBE a new method to prevent bleeding. Vasoactive drugs can be used to improve differentiation of malignant and benign diseases.
Haaga
John R
JR
Department of Radiology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA. haaga@uhrad.com
D015415:Biomarkers / Q000032:analysis; D001706:Biopsy; D001778:Blood Coagulation Disorders / Q000150:complications; D003287:Contrast Media; D004059:Diffusion of Innovation; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging*; D011835:Radiation Protection; D015641:Radiography, Interventional; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed
D015415:Biomarkers; D003287:Contrast Media